Two-year interim safety results of the 0.2 µg/day fluocinolone acetonide intravitreal implant for the treatment of diabetic macular oedema: the observational PALADIN study.

Document Type

Journal Article

Publication Date

3-1-2021

Journal

The British Journal of Ophthalmology

Volume

105

Issue

3

Inclusive Pages

414-419

DOI

10.1136/bjophthalmol-2020-315984

Comments

Epub 2020 May 27

Peer Reviewed

1

Find in your library

Share

COinS